Form 3 - Initial statement of beneficial ownership of securities:
SEC Accession No. 0001437749-14-012741
Filing Date
2014-07-14
Accepted
2014-07-14 20:15:03
Documents
2
Period of Report
2014-07-10

Document Format Files

Seq Description Document Type Size
1 FORM 3 rdgdoc.html 3  
1 FORM 3 rdgdoc.xml 3 1329
2 exhibit24.htm EX-24 14751
  Complete submission text file 0001437749-14-012741.txt   17511
Mailing Address 708 THIRD AVENUE SUITE 210 NEW YORK NY 10017
Business Address 708 THIRD AVENUE SUITE 210 NEW YORK NY 10017 914-606-3500
IMMUNE PHARMACEUTICALS INC (Issuer) CIK: 0001208261 (see all company filings)

EIN.: 521841431 | State of Incorp.: DE | Fiscal Year End: 1231
SIC: 2834 Pharmaceutical Preparations

Mailing Address 90, FAIRMOUNT ROAD WEST CALIFON NJ 07830-3330
Business Address
Durrant Cameron (Reporting) CIK: 0001421882 (see all company filings)

Type: 3 | Act: 34 | File No.: 000-51290 | Film No.: 14974507